Other competencies
- Specialist in hematology (FMH)
- Specialist in internal medicine and
- Hematology and oncology (D)
Additional qualification in palliative medicine (D)
Career
| Since 2022 | Attending Physician and research group leader, Laboratory for Molecular Leukemia Research, Department of Medical Oncology and Hematology, University Hospital Zurich |
|---|---|
| 2022 | Habilitation and authorization to teach internal medicine and hematology and oncology, University of Tübingen |
| 2022 | Additional qualification in palliative medicine, District Medical Association of South Württemberg |
| 2022 | Specialist in internal medicine and hematology and oncology, District Medical Association of South Württemberg |
| 2021 | Habilitation and authorization to teach experimental medicine, University of Tübingen |
| 2016-2021 | Ph.D. Experimental Medicine Program, University of Tübingen |
| since 2016 | Research Group Leader Laboratory for Molecular Leukemia Research and Clinician Scientist, University of Tübingen |
| 2013-2016 | Postdoctoral Fellow, Department of Pathology, Stanford University, USA |
| 2012-2022 | Doctor in postgraduate training, Internal Medicine II, University Hospital Tübingen |
Research focus
- MLL and BCR/ABL translocated leukemias
- Genome editing, CRISPR/Cas9 system
- Pathological signaling pathways and their therapeutic influence
- Leukemia models for testing new substances
- Cellular therapies and immunotherapies
Publication list
Show publication listFurther
2017
Württembergischer Krebspreis der Dres. Bayer-Stiftung
2014-2016
Stipendiatin des Dr. Mildred-Scheel-Postdoktorandenprogramms, Deutsche Krebshilfe
2014
Cheryl Whitlock Memorial Award, Stanford University
2013
Carl Liebermeister-Preis zur Promotion, Universität Tübingen